Lv31
228 积分 2024-03-29 加入
Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease
9小时前
已完结
Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry
3天前
已完结
Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
5天前
已完结
Changes in REVEAL Lite 2 risk status are associated with long-term outcomes in patients with pulmonary arterial hypertension: A post-hoc analysis of the GRIPHON study
7天前
已完结
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
7天前
已完结
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intraabdominal infections
1个月前
已完结
Comparison of the efficacy, safety and quality of life of pegylated liposomal doxorubicin-cyclophosphamide versus epirubicin-cyclophosphamide in patients with early stage HER2-negative breast cancer: A prospective, randomized, multicenter, Phase II study
2个月前
已完结
Oral Muvalaplin for Lowering of Lipoprotein(a)
3个月前
已完结
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
3个月前
已完结
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction
3个月前
已完结
皖公网安备34019202002308
